Climb Bio Stock (NASDAQ: CLYM) stock price, news, charts, stock research, profile.
You can purchase shares of Climb Bio (NASDAQ:CLYM) through any online brokerage.
Other companies in Climb Bio’s space includes: Cabaletta Bio (NASDAQ:CABA), Monopar Therapeutics (NASDAQ:MNPR), Aligos Therapeutics (NASDAQ:ALGS), PepGen (NASDAQ:PEPG) and Atossa Therapeutics (NASDAQ:ATOS).
There is no analysis for Climb Bio to provide a consensus price target.
The stock price for Climb Bio (NASDAQ: CLYM) is $2.06 last updated December 24, 2024 at 2:07 PM EST.
There are no upcoming dividends for Climb Bio.
Climb Bio’s Q3 earnings are confirmed for Tuesday, November 12, 2024.
There is no upcoming split for Climb Bio.
Climb Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.